EBC - ON DEMAND
Three-Year Clinical Outcomes of SMART-STRATEGY-Randomized Trial
European Bifurcation Club 2015 – EBC 2015 – Athens, Greece
News (2)
Three-Year Clinical Outcomes of SMART-STRATEGY-Randomized Trial
Author: Joo-Yong Hahn, Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Korea
SMART-STRATEGY trial
- Objective
- To determine the optimal indications for SB ballooning and/or stenting in the provisional approach
- Design
- Prospective, randomized, open-label, single-center study comparing conservative vs. aggressive strategy for SB treatment
SUMMARY
- At 3 years, conservative strategy was associated with a lower incidence of TVF mainly due to decreased risk of cardiac death or MI and TLR in the MV.
- The clinical benefits of a conservative strategy for provisional SB intervention was remarkable between 1 year and 3 years in landmark analysis .
- The conservative strategy might be considered as the preferred approach for provisional SB intervention.